Objective To investigate whether pulse pressure variation( ΔPP) reflect the effects of PEEP and fluid resuscitation ( FR) on hemodynamic effects. Methods Twenty critical patients with acute lung injury was ventilated with volume control ( VT =8 mL/kg, Ti/Te = 1∶2) , and PaCO2 was kept at 35 to 45 mm Hg. PEEP was setted as 5 cm H2O and 15 cmH2O in randomized order. Hemodynamic parameters including cardiac index, pulse pressure, central venous pressure, etc. were monitered by PiCCO system.Measurements were performed after the application of 5 cmH2O PEEP ( PEEP5 group) and 15 cm H2OPEEP ( PEEP15 group) respectively. When the PEEP-induced decrease in cardiac index ( CI) was gt; 10% ,measurements were also performed after fluid resuscitation. Results Compared with PEEP5 group, CI was decreased significantly in PEEP15 group( P lt;0. 05) , and ΔPP was increased significantly( P lt; 0. 05) . In 14 patients whose PEEP-induced decrease in CI was gt; 10% , fluid resuscitation increased CI from ( 3. 01 ±0. 57) L·min - 1·m- 2 to ( 3. 62 ±0. 68) L·min- 1 ·m- 2 ( P lt;0. 01) , and decreased ΔPP from ( 17 ±3) % to ( 10 ±2) % ( P lt;0. 01) . PEEP15 -induced decrease in CI was correlated negatively with ΔPP on PEEP5 ( r= - 0.91, P lt;0. 01) and with the PEEP15 -induced increase in ΔPP ( r = - 0. 79, P lt;0. 01) . FR-induced changes in CI correlated with ΔPP before FR ( r =0. 96, P lt; 0. 01) and with the FR-induced decrease in ΔPP ( r= - 0. 95, P lt; 0. 01) . Conclusions In ventilated patients with ALI, ΔPP may be a simple anduseful parameter in predicting and assessing the hemodynamic effects of PEEP and FR.
Objective To evaluate the effects and the clinical significances of liquid resuscitation on blood gas analysis， acid-base balance， electrolytes， acute physiology and chronic health evaluationsⅡ（APACHEⅡ） score of patients with septic shock， and then to analyze the relations between serum chlorine （Cl－） level and APACHEⅡscore and the volume of liquid resuscitation. Methods According to the target of resuscitation （centre venous pressure 8-12mm Hg and mean arterial pressure≥65mm Hg）， 21 patients with septic shock received enough fluid for resuscitation during 24h . The results of blood gas analysis， acid-base balance， electrolytes， and APACHE Ⅱ score were compared between pre-resuscitation and 24h post-resuscitation by self-controlled prospective study. The relationships of the level of serum Cl－ and APACHEⅡ score with the volume of liquid used in resuscitation were analyzed . Results The mean resus-citation duration was （18.09±4.57） h， and the volume of liquid during 24 h resuscitation was 5 320-11 028mL with mean volume of （7 775±1 735） mL in 21 patients with septic shock. Serum sodium （Na＋， mmol/L） and Cl－（mmol/L）levels of post-resuscitation were significant higher than those of pre-resuscitation （Na＋：138.71±5.67 versus 135.62±7.23， P=0.024；Cl－：109.10±4.90 versus 101.67±8.59， P=0.000）. Compared with the levels of pre-resuscitation， the blood pH value， hematocrit （Hct，%）， anion gap （AG， mmol/L）， lactic acid （mmol/L）， and APACHE Ⅱscore significantly decreased （pH：7.31±0.05 versus 7.37±0.06， P=0.000；Hct：28.48±2.56 versus 32.76±9.19， P=0.049；AG：8.33±3.45 versus 14.17±8.83， P=0.004；lactic acid：1.66±0.89 versus 2.96±1.23， P=0.001；APACHEⅡ：10.90±3.73 versus 17.24±4.06， P=0.000） after 24h resuscitation. The correlation analysis showed that the level of serum Cl- was positively correlated with the volume of liquid used in resuscitation （r=0.717，P＜0.01）. However， there was no correlation between APACHEⅡscore and the volume of liquid used in resuscitation （P＞0.05）. Conclusions The target of liquid resuscitation in patients with septic shock should be cautiously determined， including control of the volume of crystal liquid for resuscitation， in order to avoid acid-base imbalance or hyperchloraemia. At the same time， the change in internal environment should be monitored. An optimistic fluid resuscitation to decrease APACHE Ⅱ score in patients with septic shock is unrelated to the volume of liquid resuscitation.
Objective To evaluate the effectiveness of fluid therapy on an early goal-directed approach to resuscitation basis and the standard fluid therapy of adequate resuscitation on the prognosis of severe acute pancreatitis （SAP）in early stage. Methods The clinical data of SAP patients admitted to surgical intensive care unit within 72 h after onset of symptoms from January 2000 to November 2011 were analyzed retrospectively. A total of 97 patients with a confirmed diagnosis of SAP were divided into two groups based on whether adopting the early goal-directed fluid resuscitation strategies or not. Patients admitted from January 2000 to December 2004 did not adopt the early goal-directed fluid resuscitation strategies，therefore，being allocated into standard fluid therapy group （n=34）； patients admitted from January 2005 to November 2011 adopted the early goal-directed fluid resuscitation strategies and who were allocated into early goal-directed fluid therapy group （n=63）. With the exception of the fluid therapy strategies，the two group patients received standard treatment for SAP. The acute physiology and chronic health evaluation Ⅱ score （APACHEⅡ） and multiple organ dysfunction score （Marshall）， rate of multiple organ dysfunction syndrome （MODS） within the first week after admission，pancreatic infection rate，and in-hospital mortality were compared between the two groups. Results Compared with the standard fluid therapy group on day 3 after admission，APACHEⅡ score and Marshall score decreased significantly in the early goal-directed fluid therapy group （APACHEⅡ score：7.38±4.01 versus 11.35±4.27， P=0.011；Marshall score：4.13±2.06 versus 6.82±3.15， P=0.016）. In addition，patients in the early goal-directed fluid therapy group experienced a trend toward lower rates of MODS with the first week after admission，pancreatic infection，and in-hospital mortality （rate of MODS：46.0% versus 61.8%，P=0.139；rate of pancreatic infection：31.7% versus 44.1%， P=0.226；in-hospital mortality：15.8% versus 23.5%，P=0.355） that did not reach statistical significance. Conclusion Although early goal-directed fluid therapy for SAP in acute response stage may have ameliorated the patient’s condition and improved outcome to a certain degree，carefully designed human clinical trials should be performed in a randomized controlled manner to assess the role of such fluid resuscitation in SAP.
ObjectiveTo systematically review the efficacy and safety of high-versus low-chloride content in fluid resuscitation during perioperative and critical care. MethodsDatabases including The Cochrane Library (Issue 5, 2015), Web of Science, PubMed, CNKI, VIP, CBM and WanFang Data were searched to collect relevant randomized controlled trials (RCTs) about high-versus low-chloride content in fluid resuscitation from inception to May 2015. Two reviewers independently screened literature, extracted data, and assessed the risk of bias of included studies. Then meta-analysis was performed by using RevMan 5.2 software. ResultsA total of 15 RCTs involving 772 participants were included. The results of meta-analysis indicated that there were no significant differences in mortality (RR=1.30, 95% CI 0.59 to 2.89, P=0.52), incidence of acute kidney injury (RR=1.66, 95% CI 0.83 to 3.31, P=0.15), the level of serum creatinine (MD=0.05, 95% CI-0.06 to 0.15, P=0.38), urine output (MD=0.61, 95% CI-1.11 to-2.33, P=0.48), transfusion volume (MD=86.01, 95% CI-37.80 to 209.82, P=0.17), hospital length of stay (LOS) (MD=-0.27, 95% CI-1.11 to 0.58, P=0.54) and ICU LOS (MD=-0.97, 95% CI-3.31 to 1.37, P=0.42) between the high-chloride content group and the low-chloride content group. While the level of serum chlorine in the high-chloride content group was higher than that in the low-chloride content group (MD=5.40, 95% CI 1.68 to 9.12, P=0.004). ConclusionCurrent evidence shows, there is no difference between high-versus low-chloride content in fluid resuscitation during perioperative and critical care. Due to the limited quality and quantity of the included studies, more high quality studies are need to verify the above conclusion.
The publication of the 2016 version of the Surviving Sepsis Campaign guidelines is a further step to the treatment of sepsis worldwide. This version of guidelines approves new definition of Sepsis-3. Overall, the new guidelines do not change the previous principle of treatment significantly. Some detailed and specific modifications have been made. Understanding and rational use of the new guidelines based on clinical practice, are the key to managing sepsis and performing accurate and effective treatment.